Constellation Brands Inc. (STZ)

183.90
2.64 1.46
NYSE : Consumer Non-Durables
Prev Close 181.26
Open 181.76
Day Low/High 181.76 / 184.27
52 Wk Low/High 150.37 / 233.00
Volume 2.26M
Avg Volume 1.83M
Exchange NYSE
Shares Outstanding 167.21M
Market Cap 35.23B
EPS 18.20
P/E Ratio 10.46
Div & Yield 3.00 (1.60%)

Latest News

Caesars, FedEx, Trade Talks, Daimler and 'Toy Story 4' - 5 Things You Must Know

Caesars, FedEx, Trade Talks, Daimler and 'Toy Story 4' - 5 Things You Must Know

U.S. stock futures rise as investors look to the upcoming G-20 summit in Osaka, Japan, for a breakthrough in U.S.-China trade talks; Eldorado Resorts agrees to merge with Caesars Entertainment; FedEx is forced to issue its second apology in as many months for failing to complete the shipping of a package linked to China's Huawei.

Caution Ahead: Cramer's 'Mad Money' Recap (Friday 6/21/19)

Caution Ahead: Cramer's 'Mad Money' Recap (Friday 6/21/19)

Jim Cramer explains why the stock market isn't a good gauge of the economy. Plus, he's got your game plan for next week.

At Canopy Growth it's a Question of Expansion vs. Value

At Canopy Growth it's a Question of Expansion vs. Value

Canopy Growth's latest financial results offer a reality check.

This Is Canopy Growth's Must-Hold Support Level

This Is Canopy Growth's Must-Hold Support Level

Canopy Growth stock is taking a beating on Friday after the company disappointed investors with its quarterly results. Here's the must-hold support level for the stock now.

Should Investors Buy the Dip in Canopy Growth Stock?

Should Investors Buy the Dip in Canopy Growth Stock?

Canopy's earnings losses could just be a stepping stone to becoming the industry leader.

Reducing a Winner

We’ll trim our position in Aurora Cannabis in order to protect some gains.

Canopy Growth Shares Slump After Q4 Earnings; Canadian Pot Sales Slow

Canopy Growth Shares Slump After Q4 Earnings; Canadian Pot Sales Slow

Canopy Growth shares trade sharply lower Friday after the Canadian cannabis company posts a wider-than-expected fourth-quarter loss and says recreational sales slowed from the previous three-month period.

Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly

Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly

The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.

Canopy Growth Slips as Production, Margins Disappoint

Canopy Growth Slips as Production, Margins Disappoint

While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.

Iran, Trump, Canopy Growth, Slack, Zion Williamson - 5 Things You Must Know

Iran, Trump, Canopy Growth, Slack, Zion Williamson - 5 Things You Must Know

U.S. stock futures decline following a report that President Donald Trump ordered, and then rescinded, an airstrike on military installations in Iran; Canopy Growth posts better-than expected fiscal fourth-quarter revenue but a wider loss; Slack extends gains; Zion Williamson is picked No. 1 in the NBA Draft.

Canopy Growth Tops Revenue Estimates, Warns of 'Material Non-Cash Charge'

Canopy Growth Tops Revenue Estimates, Warns of 'Material Non-Cash Charge'

Canadian cannabis company posts fourth-quarter results.

Best and Worst Beer Stocks

Best and Worst Beer Stocks

Wetting my whistle with these 2 beer names, plus 2 stocks to avoid.

Constellation Brands and GM Would Be Stocks Exposed to Mexican Trade Tariffs

Constellation Brands and GM Would Be Stocks Exposed to Mexican Trade Tariffs

The ripples of Mexican tariffs will spread far and wide, through a multitude of economic sectors. Let's take a look at Constellation Brands and General Motors to see how the tariffs will impact them and how they are likely to react.

Constellation Brands, Beverage Stocks Go Flat on Proposed Tariffs on Mexico

Constellation Brands, Beverage Stocks Go Flat on Proposed Tariffs on Mexico

Shares of Constellation Brands and other beverage companies take a hit from the threatened tariffs on Mexican goods.

Trouble Brewing at Constellation Brands

Trouble Brewing at Constellation Brands

For me, this one is a pass. For now.

Constellation Brands Falls on Morgan Stanley Downgrade

Constellation Brands Falls on Morgan Stanley Downgrade

Morgan Stanley knocks its rating on the nation's No. 3 beer maker down to equal-weight from overweight.

Canopy Growth Names Former Constellation Brands Exec as Acting Finance Chief

Canopy Growth Names Former Constellation Brands Exec as Acting Finance Chief

Canadian marijuana manufacturer Canopy Growth appoints former Constellation Brands' senior executive Mike Lee as the company's acting chief financial officer.

Trimming a Position and What to Make of an Earnings Report

Energy Recovery has stabilized above our target, warranting some action. Plus, Aurora Cannabis reports earnings.

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Curious about the cannabis sector? Here's what Tilray and Aurora's earnings mean for the sector.

Constellation Brands CEO Bill Newlands Celebrates Cinco de Mayo With TheStreet

Constellation Brands CEO Bill Newlands Celebrates Cinco de Mayo With TheStreet

The company behind Corona beer is up 32% year to date, and its big investment in Canopy Growth could mean that the party's just getting started.

Ask Cramer: Cannabis ETF vs. Individual Stock: Which to Buy?

Ask Cramer: Cannabis ETF vs. Individual Stock: Which to Buy?

Should you buy cannabis ETF instead of attempting to pick an individual stock?

Cramer: Why Cannabis-Infused Drinks Could Mean New Highs for 2 Companies

Cramer: Why Cannabis-Infused Drinks Could Mean New Highs for 2 Companies

Weed-infused drinks will be big in 2019. So, how should investors play it? Watch TheStreet's Cramer Live Show for more.

Jim Cramer: It's 420, Here's How to Play the Cannabis Sector

Jim Cramer: It's 420, Here's How to Play the Cannabis Sector

It's 420. TheStreet's Jim Cramer discusses Canopy Growth, Tilray, Constellation Brands and other investing opportunities in the cannabis sector!

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

The Economy is Riding the Rails: Cramer's 'Mad Money' Recap (Wednesday 4/17/19)

The Economy is Riding the Rails: Cramer's 'Mad Money' Recap (Wednesday 4/17/19)

If you want a good read on the economy, look at the details of CSX's latest earnings report.

Nvidia, Advanced Micro Devices, Constellation: 'Mad Money' Lightning Round

Nvidia, Advanced Micro Devices, Constellation: 'Mad Money' Lightning Round

Jim Cramer weighs in on Nvidia, Advanced Micro Devices, Constellation Brands, Bausch Health, Arista Networks, Gilead Sciences and more.

I Own Alphria Stock and the Big Q3 Loss Was Not a Surprise

I Own Alphria Stock and the Big Q3 Loss Was Not a Surprise

The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.

2 Huge Earnings Reports I'm Watching This Week

2 Huge Earnings Reports I'm Watching This Week

A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.

TheStreet Quant Rating: B (Buy)